Body Weight-Based Interval Training in Sedentary Overweight and Obese Adults

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 17-010163
    NCT ID: NCT03524521
    Sponsor Protocol Number: 17-010163

About this study

Body-weight based interval training (IT) performed 3 times per week will lead to reductions in abdominal adiposity and reduce overall body fat percentage in overweight and obese sedentary adults more effectively than moderate intensity continuous training (MICT). Body-weight interval training will improve exercise capacity (peak VO2) in overweight/obese adults.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Adults 18-65 years of age
  • Willing and able to provide informed consent
  • Sedentary, overweight and obese adults (<90 minutes of moderate intensity exercise)
  • BMI 25≤35
  • Able to safely begin an exercise program
  • Have a smartphone, and willing and able to download and use the Fitbit app

Exclusion Criteria:

  • Unable to provide informed consent.
  • Known cardiovascular disease, or uncontrolled hypertension,
  • Diagnosed type 1 or 2 diabetes
  • Women who are pregnant or plan to become pregnant in the next 3-4 months
  • Orthopedic injury/limitation or any other contraindications to exercise.
  • Medications that cause weight gain (steroids, HIV-related medications, etc.), or glucose lowering medications

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Amanda Bonikowske, Ph.D.

Open for enrollment

Contact information:

Jeremy Smith

(507)255-2831

Smith.Jeremy@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20423269

Mayo Clinic Footer